Market Insight : Cardiac Resynchronization Theapy Devices Market in Europe Grow at a CAGR of 8.09% by Revenue During the Forecast Period 2017-2019
ResearchMoz presents professional and in-depth study of "Cardiac Resynchronization Theapy Devices Market in Europe 2015 - 2019". According to WHO, cardiovascular diseases accounted for more than half of all deaths in the European region. The annual overall cost of cardiovascular diseases in the top five European countries is estimated to be $90.10 billion, of which 54% is attributed to healthcare costs, 24% to loss in productivity, and 22% to informal care. CRT devices are implantable devices that are used to resynchronize contractions of the hearts ventricles by sending tiny electrical impulses to the muscles of the heart. CRT is an effective therapy for patients suffering from heart failure and arrhythmias. Technavio's analysts forecast the cardiac resynchronization therapy devices market in Europe to grow at a CAGR of 8.09% over the period 2014-2019. Covered in this Report The report includes the present scenario and the growth prospects of the cardiac resynchronizati...